We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

Fasenra

ACNU Feasibility

View full report
OKFasenra is a subcutaneous injection with moderate side effects and requires regular monitoring. It has low misuse potential but complex dosing and adherence challenges, especially in special populations. Safety in children and pregnant women remains uncertain.

ACNU Feasibility Scorecard

Chart with 11 data points.
Fasenra
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 8.
End of interactive chart.